Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report
Authors (first, second and last of 12)

The official journal of the Japanese Breast Cancer Society, Breast Cancer publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research. It develops a new focus and new perspectives for all who are concerned with breast cancer.
Breast Cancer presents original articles describing clinical, epidemiological studies and laboratory investigations regarding breast cancer and related diseases. It features editorials, review articles, original articles, case reports, and short papers. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
2020 Best of Breast Cancer winners
The JBCS editorial committee has selected the following as the most influential articles from Breast Cancer:
・Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction
・High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study
・Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey
・Influence of breast density on breast cancer risk: a case control study in Japanese women
・Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004–2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society
・Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
・Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
・Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer
・Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema
・Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines
・Microsatellite instability in Japanese female patients with triple-negative breast cancer